- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01932346
Using Near Infra-red Spectroscopy to Measure Tissue Perfusion in Patients Receiving Coronary Artery Bypass Graft Surgery
Using Non-invasive Near Infra-red Spectroscopy to Measure the Regional Tissue Perfusion in Patients Receiving Off-pump Coronary Artery Bypass Graft Surgery
Study Overview
Status
Conditions
Detailed Description
Study Design:
Prospective observational study
Target Number of Participants:
To recruit 50 patients into this study.
Patient Selection:
- Patients scheduled for elective coronary artery bypass surgery.
- The American Society of Anesthesiologists physical status classification system(ASA) Class I~III
- Age ≧20 y/o, ≦75 y/o
Exclusion Criteria:
- ASA Class IV
- Current skin lesion over the sites where the NIRS patches are designed to be attached.
- Patients received cardiopulmonary bypass during the surgery.
- Patients with previous history of allergy to the NIRS patches.
Study Method:
After the induction of anesthesia, four NIRS patches are attached to the patients on the following sites:
- Biceps brachii muscle area
- Gastrocnemius muscle area
- Posterior side of neck
- central part of the forehead
The four non-invasive NIRS patches are only to measure the tissue oxygen saturation and have no other physiological effects on the participants.
The data will be collected every 5 minutes until the surgery is completed. The data from other routine monitors used during the surgery (including hear rate, blood pressure, and mixed venous saturation) will also be used to compare with the data from NIRS.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Po-Yuan Shih
- Email: b87401084@ntu.edu.tw
Study Locations
-
-
-
Taipei, Taiwan
- Recruiting
- Using non-invasive near infra-red spectroscopy to measure the regional tissue perfusion in patients receiving off-pump coronary artery bypass graft surgery
-
Contact:
- Po-Yuan Shih
- Email: b87401084@ntu.edu.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≧20 years old, ≦75 years old
- Patients scheduled for elective coronary artery bypass surgery
- ASA Class I~III
Exclusion Criteria:
- Patients scheduled for cardiopulmonary bypass
- Allergy for NIRS
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of tissue oxygen saturation (StO2)
Time Frame: every 5 minute, from the induction of anesthesia to the end of the surgery, estimated duration: 4 hours
|
The measured tissue oxygen saturation is shown in the form of percentage (0~100%).
|
every 5 minute, from the induction of anesthesia to the end of the surgery, estimated duration: 4 hours
|
Collaborators and Investigators
Investigators
- Principal Investigator: Po-Yuan Shih, National Taiwan University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201201016RIC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina